Complete remission of MDS RAEB following immunosuppressive treatment in a patient with Sweet's syndrome

Netherlands Journal of Medicine

Volumn 67, Issue 8, 2009, Pages 347-350

  Ten Oever, J ^a   Kuijper, P H M ^a   Kuijpers, A L A ^a   Dercksen, M W ^a   Vreugdenhi, G ^a  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

Complete remission; Corticosteroids; Doxycycline; Histiocytoid Sweet's syndrome; Myelodysplastic syndrome; Natural killer cells

Indexed keywords

CEFTRIAXONE; CORTICOSTEROID; DOXYCYCLINE; ERYTHROPOIETIN; FOLIC ACID; METHYLPREDNISOLONE; PREDNISONE; PYRIDOXINE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADD ON THERAPY; AGED; ANAMNESIS; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; CASE REPORT; CELLULAR IMMUNITY; COMORBIDITY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOPHENOTYPING; MALE; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PANCYTOPENIA; SKIN BIOPSY; SKIN DEFECT; T LYMPHOCYTE; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION;

ADRENAL CORTEX HORMONES; AGED; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; MALE; RECURRENCE; REMISSION INDUCTION; SWEET SYNDROME; TREATMENT OUTCOME;

EID: 70349684746     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Atallah E, Garcia-Manero G. Treatment strategies in myelodysplastic syndromes. Cancer Invest. 2008;26:208-216
2. Marisavljevic D, Rolovic Z, Ludoski-Pantic M, Djordjevic V, Novak A. Spontaneous remission in adults with primary myelodysplastic syndromes: incidence and characteristics of patients. Med Oncol. 2005;22:407-410 (Pubitemid 43780298)
3. Maywald O, Buchheidt D, Bergmann J, et al. Spontaneous remission in adult myeloid leukemia in association with systemic bacterial infection - case report and review of the literature. Ann Hematol. 2004;83:189-194 (Pubitemid 38292241)
4. Mitterbauer M, Fritzer-Szekeres M, Mitterbauer G, et al. Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol. 1996;73:189-193 (Pubitemid 26381699)
5. Musto P, D'Arena G, Melillo L, et al. Spontaneous remission in acute myeloid leukaemia: a role for endogenous production of tumour necrosis factor and interleukin-2? Br J Haematol. 1994;87:879-880
6. Nand S, Stock W, Stiff P, Sosman J, Martone B, Radvany R. A phase II trial of interleukin-2 in myelodysplastic syndromes. Br J Haematol. 1998;101:205-207 (Pubitemid 28197796)
7. Warlick ED, Smith BD. Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches. Curr Cancer Drug Targets. 2007;7:541-558 (Pubitemid 47358141)
8. Sloand EM, Rezvani K. The role of the immune system in myelodysplasia: implications for therapy. Semin Hematol. 2008;45:39-48.
9. Kiladjian JJ, Fenaux P, Caignard A. Defects of immune surveillance offer new insights into the pathophysiology and therapy of myelodysplastic syndromes. Leukemia. 2007;21:2237-2239 (Pubitemid 350011694)
10. Kiladjian JJ, Bourgeois E, Lobke I et al. Cytolytic function of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia. 2006;20:463-470 (Pubitemid 43291745)
11. Rosenfeld CS, Zeigler ZR, Shadduck RK, Nilsson B. Phase II study of roquinimex in myelodysplastic syndrome. Am J Clin Oncol. 1997;20:189-192 (Pubitemid 27152776)
12. Toze CL, Barnett MJ, Klingemann HG. Response of therapy-related myelodysplasia to low-dose interleukin-2. Leukemia. 1993;7:463-465
13. Yamada T, Tsurumi H, Kasahara S, Hara T, Sawada M, Moriwaki H. Immunosuppressive therapy for myelodysplastic syndrome: efficacy of methylprednisolone pulse therapy with or without cyclosporin A. J Cancer Res Clin Oncol. 2003;129:485-491 (Pubitemid 37056156)
14. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol. 2000;37:15-29.
15. Reza S, Shetty V, Dar S, Qawi H, Raza A. Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes. J Interferon Cytokine Res. 1998;18:871-877 (Pubitemid 28489666)
16. Iwasaki H, Inoue H, Mitsuke Y, Badran A, Ikegaya S, Ueda T. Doxycycline induces apoptosis by way of caspase-3 activation with inhibition of matrix metalloproteinase in human T-lymphoblastic leukemia CCRF-CEM cells. J Lab Clin Med. 2002;140:382-386 (Pubitemid 36017058)
17. Van den Bogert C, Dontje BH, Kroon AM. Doxycycline in combination chemotherapy of a rat leukemia. Cancer Res. 1988;48:6686-6690 (Pubitemid 19012189)